The Japanese Biochemical Society

[1P-070(1T09-06)] sPLA2-IID prevents anti-cancer immunity

Yu Kidoguchi1,2, Kei Yamamoto1,3,4, Yoshimi Miki1, Makoto Murakami1,5 (1.Lipid Metab. , Tokyo Metro. Inst. of Med. Sci., 2.Div. of Life Sci. and Eng., Grad. Sch. of Sci. and Eng., Tokyo Denki Univ., 3.Fac. of Biosci. and Bioind., Tokushima Univ., 4.PRIME, 5.AMED-CREST)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 2:45 PM - 3:45 PM

[1P-071(1T09-03)] The role of oxidized phospholipid-derived lipid mediators in IgE-mediated mast cell activation

Yuta Shimanaka1, Nozomu Kono1,2, Yoshitaka Taketomi3, Makoto Arita4, Makoto Murakami3,5, Hiroyuki Arai1,5 (1.Department of Health Chemistry, Graduate School of Pharmaceutical Sciences, the University of Tokyo, Japan, 2.PRIME, AMED, 3.Lipid Metabolism Project, Tokyo Metropolitan Institute of Medical Science, Japan, 4.Laboratory for Metabolomics, RIKEN Center for Integrative Medical Sciences, Japan, 5.AMED-CREST, AMED)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 1:30 PM - 2:45 PM

[1P-072(1T09-07)] sPLA2-III deficiency ameliorates atherosclerosis

Yoshitaka Taketomi1, Takuro Miyazaki2, Yoshimi Miki1, Hiroyasu Sato1, Makoto Murakami1,3 (1.Lipid Metab, Tokyo Metr. Inst. of Med. Sci., 2.Dept. of Biochem, Showa Univ. Sch. of Med., 3.AMED-CREST)

The 89th Annual Meeting of JBS |Sun. Sep 25, 2016 2:45 PM - 3:45 PM